SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 183 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $90,000 | -19.6% | 69,819 | -20.6% | 0.00% | – |
| Q4 2021 | $112,000 | -76.6% | 87,887 | -59.9% | 0.00% | -100.0% |
| Q3 2021 | $478,000 | -40.3% | 219,328 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $801,000 | +13.0% | 213,504 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $709,000 | -4.7% | 217,512 | -0.4% | 0.00% | 0.0% |
| Q4 2020 | $744,000 | -16.5% | 218,297 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $891,000 | +53.9% | 218,297 | +27.4% | 0.00% | 0.0% |
| Q2 2020 | $579,000 | +45.1% | 171,375 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $399,000 | -35.3% | 171,375 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $617,000 | -57.5% | 169,390 | -3.2% | 0.00% | -66.7% |
| Q3 2019 | $1,452,000 | -1.8% | 174,996 | +1.9% | 0.00% | 0.0% |
| Q2 2019 | $1,478,000 | -11.1% | 171,657 | +10.4% | 0.00% | 0.0% |
| Q1 2019 | $1,662,000 | +20.3% | 155,516 | -1.5% | 0.00% | 0.0% |
| Q4 2018 | $1,382,000 | -46.7% | 157,930 | +2.4% | 0.00% | -40.0% |
| Q3 2018 | $2,592,000 | -18.4% | 154,262 | +1.8% | 0.01% | -28.6% |
| Q2 2018 | $3,176,000 | +49.2% | 151,544 | +14.5% | 0.01% | +40.0% |
| Q1 2018 | $2,129,000 | -18.0% | 132,334 | -3.4% | 0.01% | 0.0% |
| Q4 2017 | $2,596,000 | +48.1% | 136,973 | +9.9% | 0.01% | +25.0% |
| Q3 2017 | $1,753,000 | +70.5% | 124,603 | -9.7% | 0.00% | +100.0% |
| Q2 2017 | $1,028,000 | +3.6% | 137,965 | -9.6% | 0.00% | 0.0% |
| Q1 2017 | $992,000 | +40.3% | 152,665 | -4.3% | 0.00% | +100.0% |
| Q4 2016 | $707,000 | -7.7% | 159,565 | -2.7% | 0.00% | -50.0% |
| Q3 2016 | $766,000 | -17.0% | 164,065 | +16.8% | 0.00% | 0.0% |
| Q2 2016 | $923,000 | +2.3% | 140,465 | -1.0% | 0.00% | 0.0% |
| Q1 2016 | $902,000 | +20.4% | 141,865 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $749,000 | +2.7% | 124,158 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $729,000 | -12.9% | 121,958 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $837,000 | +15.1% | 122,358 | +2.2% | 0.00% | 0.0% |
| Q1 2015 | $727,000 | -13.9% | 119,744 | -1.6% | 0.00% | 0.0% |
| Q4 2014 | $844,000 | -14.5% | 121,744 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $987,000 | +1.4% | 121,227 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $973,000 | +7.9% | 119,740 | +4.1% | 0.00% | 0.0% |
| Q1 2014 | $902,000 | -11.0% | 115,040 | +0.5% | 0.00% | -33.3% |
| Q4 2013 | $1,013,000 | +6.1% | 114,440 | +0.5% | 0.00% | 0.0% |
| Q3 2013 | $955,000 | +22.4% | 113,840 | +8.8% | 0.00% | 0.0% |
| Q2 2013 | $780,000 | +1.3% | 104,602 | +1.3% | 0.00% | 0.0% |
| Q1 2013 | $770,000 | – | 103,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |